Inhaled Steroid Mometasone May Reduce Macrophage Marker Levels in Sickle Cell Disease
Mometasone usage was found to correlate with decreased levels of macrophage markers but not of asthma-related markers.
All articles by Megan Garlapow, PhD
Apixaban May Reduce Risk for Venous Thromboembolism in Patients With Cancer
Significantly fewer patients receiving apixaban experienced thromboembolism and major bleeding compared with patients receiving placebo.
No Association Found Between Locations of Venous Thromboembolism and Occult Cancer
An analysis of 2300 patients found similar prevalence of abdominal, pelvic, and thoracic cancer in patients with deep vein thrombosis and pulmonary embolism.
New Indication of Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis
The ASBMT released a position statement recommending autologous hematopoietic cell transplantation as treatment for relapsing multiple sclerosis.
Congenital Bleeding Disorders Not Associated With Increased Endoscopic Bleeding Risk With Proper Prophylaxis
Researchers conducted a retrospective chart review to assess the bleeding risk associated with gastrointestinal endoscopy.
Glucagon-Like Peptide-1 May Predict Inflammation in High-Dose Chemotherapy With Autologous Stem Cell Transplantation
Researchers measured levels of glucagon-like peptide-1 and C-reactive protein to determine their value as predictive biomarkers of toxicity.
Novel Risk Factors for Venous Thromboembolism in Pregnancy and Postpartum
Researchers assessed potential risk factors for venous thromboembolism during pregnancy and postpartum in more than 100,000 Japanese women.
Palbociclib Plus Ibrutinib in Patients With Previously Treated Mantle Cell Lymphoma
Results from a phase 1 trial suggested that patients with previously treated mantle cell lymphoma may respond positively to ibrutinib plus palbociclib.
Thromboprophylaxis May Not Benefit Patients With Advanced Cancer in Palliative Care
Thromboprophylactic treatment and serum albumin levels were not found to be associated with deep vein thrombosis incidence.
Long-Term Outcomes of Anti-T-Lymphocyte Globulin Added to Graft-Versus-Host Disease Prophylaxis
GVHD prophylaxis including anti-T-lymphocyte globulin was associated with improved survival and quality of life.
Next post in Leukemia
